Johnson & Johnson subsidiary Ethicon debuted its Vistaseal Fibrin Sealant, a product designed to help surgeons manage intraoperative bleeding.
The Latest
Palo Alto, Calif.-based Stanford University Medical Center is expanding access to neurosurgery treatments by acquiring a second CyberKnife M6 system.
Providence, R.I.-based University Orthopedics and Blue Cross Blue Shield of Rhode Island are developing a new value-based initiative for outpatient total joint replacements.
Birmingham, Ala.-based Andrews Sports Medicine & Orthopaedic Center will open a new clinic in Cullman, Ala., Jan. 6.
Grand Blanc, Mich.-based McLaren Healthcare is planning to buy St. Luke's Hospital in Maumee, Ohio, and develop a new orthopedic, spine and neuro facility.
SPR Therapeutics announced the commercial placement of its 1,000th Sprint Peripheral Nerve Stimulation system for pain was completed Dec. 4.
Birmingham, Ala.-based Encompass Health is seeking approvals for a $52.2 million rehabilitation hospital in Libertyville, Ill., reports the Daily Herald.
New York City-based Hospital for Special Surgery and the New York Giants recently extended their sports medicine partnership with a new 10-year deal, according to the New York Giants' website.
Medtronic and Lumeon entered into a strategic partnership that aims to help healthcare providers in Europe succeed with value-based care.
The FDA cleared EmCyte's Progenikine Concentrating System for adipose lipoplasty for procedures in several specialties including neurosurgery and orthopedics.